Q Bio News

Follow[dot]Health is a news alert service for Heathcare and Healthtech. We are following 40K entities across 30M news items - with 1M items added monthly. This is selected news for Q Bio, which is filed under Sectors / Healthtech. There are 50 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
4/2/2022 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update - Ticker Report
Q BioMed Inc. ( OTCMKTS:QBIO – Get Rating ) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 26,100 shares, an increase of 31.8% from the February 28th total of 19,800 shares. Based on an average ...
Ticker Report
4/2/2022 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update
Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update Posted by Stacy Sanders on Apr 2nd, 2022 Share on Stocktwits Q BioMed Inc. ( OTCMKTS:QBIO – Get Rating ) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest ...
Daily Political
3/31/2022 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update - Stock Observer
Q BioMed Inc. ( OTCMKTS:QBIO – Get Rating ) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 26,100 shares, a growth of 31.8% from the February 28th total of 19,800 shares. Based on an average daily volume of ...
thestockobserver.com
3/16/2022 Q BioMed announces publication of research showing augmented efficacy of its drug candidate Uttroside-B against liver cancer | 2022-03-16 | Press Releases | Stockhouse stockhouse.com
3/9/2022 Q BioMed (OTCMKTS:QBIO) Shares Cross Below 50 Day Moving Average of $0.42 modernreaders.com
3/7/2022 Q BioMed Announces Initial $500k Order of Strontium89 to Chinese Market PR Newswire
3/7/2022 Q BioMed Announces Initial $500k Order of Strontium89 to Chinese Market globalbankingandfinance.com
2/15/2022 Q BioMed Outlines Strategic Direction for 2022 tncontentexchange.com
2/14/2022 Q BioMed Outlines Strategic Direction for 2022 PR Newswire
2/14/2022 Q BioMed Outlines Strategic Direction for 2022 globalbankingandfinance.com
2/14/2022 Q BioMed Outlines Strategic Direction for 2022 | Insider Tracking insidertracking.com
2/14/2022 Q BioMed Outlines Strategic Direction for 2022 PR Newswire
2/14/2022 Q BioMed Outlines Strategic Direction for 2022 Yahoo News
2/5/2022 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update etfdailynews.com
8/10/2021 Q BioMed Signs Distribution Agreement with isoSolutions for the Sales of Strontium89 in Canada PR Newswire
8/10/2021 Q BioMed Signs Distribution Agreement with isoSolutions for the Sales of Strontium89 in Canada otcmarkets.com
8/10/2021 Q BioMed Signs Distribution Agreement with isoSolutions for the Sales of Strontium89 in Canada tncontentexchange.com
8/10/2021 Q BioMed Signs Distribution Agreement With isoSolutions for the Sales of Strontium89 in Canada drug-dev.com
3/30/2021 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update Daily Political
3/17/2021 Q BioMed (OTCMKTS:QBIO) and Prestige Consumer Healthcare (NYSE:PBH) Head-To-Head Review slatersentinel.com
3/4/2021 Q BioMed Inc. (OTCMKTS:QBIO) Sees Large Drop in Short Interest Ticker Report
3/3/2021 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update wkrb13.com
3/2/2021 Q BioMed announces five year contract with the US Department of Defense and Veterans Affairs for its cancer bone pain drug proactiveinvestors.com
1/27/2021 Q BioMed's Uttroside-B Receives U.S. FDA Orphan Drug Designation in the Treatment of Liver Cancer otcmarkets.com
1/7/2021 Strontium89 Now Reimbursed in Hospital and Outpatient Settings for Metastatic Bone Pain Treatment PR Newswire